GEOSPACE TECHNOLOGIES CORP (GEOS)

US37364X1090 - Common Stock

8.37  +0.04 (+0.48%)


Fundamental Rating

3

Overall GEOS gets a fundamental rating of 3 out of 10. We evaluated GEOS against 93 industry peers in the Energy Equipment & Services industry. While GEOS has a great health rating, but there are worries on its profitability. GEOS has a expensive valuation and it also scores bad on growth

Note: GEOS has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

GEOS has a Piotroski-F score of 6.00. This indicates an average health and profitability for GEOS.

VS Industry

Valuation

Valuation Rating

2

When comparing the current price to the book value of GEOS, it is valued rather cheaply. It is trading at 0.91 times its book value.
Compared to an average industry price book ratio of 1.28, GEOS is valued rather cheaply

The Price/Earnings Ratio is negative for GEOS. In the last year negative earnings were reported.
Compared to an average industry Enterprise Value to EBITDA ratio of 5.45, GEOS is valued more expensive than its industry peers. 100% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (0.91) VS Industry: 62% outperformed.

132.07
0.19

Enterprise Value/ EBITDA (121.08) VS Industry: 0% outperformed.

121.08
1.88

Growth

Growth Rating

1

The Revenue has decreased by -5.96% in the past year.
Measured over the past 5 years, GEOS shows a small growth in Revenue. The Revenue has been growing by 3.90% on average per year.

The earnings per share for GEOS have decreased strongly by -66.82% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -66.82% N/A N/A N/A N/A
Revenue3.9% -2.33% -5.96% N/A N/A N/A N/A

Health

Health Rating

9

A Current Ratio of 4.75 indicates that GEOS has no problem at all paying its short term obligations.
GEOS is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.93. GEOS has a better rating than 94% of its industry peers.
GEOS has a Quick Ratio of 3.17. This indicates that GEOS is financially healthy and has no problem in meeting its short term obligations.
GEOS is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.51. GEOS has a better rating than 88% of its industry peers.

With a Debt to Equity ratio of 0.00, GEOS is one of the better performing companies in its industry. It outperforms 95% of its industry peers.
GEOS has an Altman-Z score of 6.05. This indicates that GEOS is financially healthy and little risk of bankruptcy at the moment.
GEOS has one of the better Altman-Z scores in its industry. It is much better than the industry average of 1.77. GEOS has a better score than 93% of its industry peers.
The Piotroski-F score of GEOS is 6.00. This is a neutral score and indicates average health and profitability for GEOS.
VS Industry

Debt/Equity (0) VS Industry: 95% outperformed.

16.18
0.00

Quick Ratio (3.17) VS Industry: 88% outperformed.

0.18
8.35

Current Ratio (4.75) VS Industry: 94% outperformed.

0.18
9.02

Altman-Z (6.05) VS Industry: 93% outperformed.

-7.03
10.89

Dividend

Dividend Rating

0

No dividends for GEOS!.

GEOSPACE TECHNOLOGIES CORP

NASDAQ:GEOS (6/8/2023, 9:58:00 AM)

8.37

+0.04 (+0.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)05-11 2023-05-11/amc
Earnings (Next)08-07 2023-08-07/amc
Inst Owners36.55%
Inst Owner Change11.14%
Ins Owners5.6%
Ins Owner Change8.54%
Market Cap110.25M
Analysts85.71
Price TargetN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.24
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.96
EV/EBITDA 121.08
EPS(TTM)-1.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS6.78
BVpS9.24
TBVpS8.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 20.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.25%
GM growth 5YN/A
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 30.48%
Profit Quality N/A
Current Ratio 4.75
Quick Ratio 3.17
Altman-Z 6.05
F-Score6
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)30.5%
Cap/Depr(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-66.82%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-58.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y-5.96%
Revenue growth 3Y-2.33%
Revenue growth 5Y3.9%
Revenue growth Q2Q33.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.92%
OCF growth 3YN/A
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA